Search for
Canadian Statistics

Agriculture / Primary / Manufacturing / Transportation / Trade / Culture & Recreation / Business SvrComputer (IT) / Construction / Education / Environment / Government / Health / Hospitality / InternetJustice / Personal Srv  / Non-profit / Market Research / Economic Data



Institute of Health Economics
[If you want to visit this web site Click Above]

Use Ctrl-F to search this page for a keyword.

You must provide your e-mail before you can download the FREE reports available at this site.


  • Drug Cost List
    Provides a list of costs for specifics drugs by province. EXCEL format.


  • 2001 working papers 
    • 01-02:Strategic Orientation and Benchmarking in the Canadian Pharmaceutical and Biotechnology Industries


  • 2000 working papers 
    • 00-17: Treatment Variations of Femoral Neck Fractures in Alberta
    • 00-16: Economic Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    • 00-15: A Technology Index of Hospital Expenditure Growth in Canada
    • 00-14: Health Expenditures and Technology in the Treatment Heart Attacks
    • 00-13: A Pilot Study Assessing the Impact of Community Pharmacists Care on the Clinical and Humanistic Outcomes of People with Type 2 Diabetes
    • 00-12: A Policy Impact Analysis of Pharmaceutical Cost Containment Strategies in Alberta
    • 00-11: Development of a Disease-Specific Health-Related Quality of Life Instrument for People with Cystic Fibrosis
    • 00-10: Functional Dependence Following Hip Fracture
    • 00-09: The Public Purchase of Private Surgical Services: A Systematic Review of the Evidence on
    • 00-08: An Empirical Review of Health Expenditures and Technology
    • 00-07: Technologies Used for Managing and Preventing Acute Myocardial Infarction
    • 00-06: An Economic Evaluation of Home Care as an Alternative to Institutionalization
    • 00-05: Health Technology Assessment in Canada: A Ten Year Review, Part 2
    • 00-04: Health Technology Assessment in Canada: A Ten Year Review, Part 1
    • 00-03: Cost Effectiveness Analysis and the Societal Approach: Should the Twain Ever Meet?
    • 00-02: Public Policies Related to Drug Formularies in Canada: Economic Issues
    • 00-01: A Rapid Structured Review of Studies on Health-Related Quality of Life and Economic Evaluation in Pediatric Acute Lymphoblastic Leukemia


  • 1999 working papers 
    • 99-10: Methods of Educating the Public and Pharmacists on Prescribing, Monitoring and Use of Drugs
    • 99-09: Risk Selection and Matching in Performance-Based Contracting
    • 99-08: Health-Related Quality of Life for Adult and Pediatric Cystic Fibrosis Patients: A Regression Approach to Assessing the Impact of Recombinant Human rhDNase
    • 99-07: (An Overview) Canadian Administrative Data: Quality and Assessment
    • 99-06: Paying For Physician Services In Canada: The Institutional, Historical and Policy Contexts - Part 1 of Incentive Effects of Physician Remuneration Schemes
    • 99-05: Models for Funding Prescription Drug Programs
    • 99-04: Systematic Review of Pharmacy Reimbursement Literature
    • 99-03: A Systematic Review of Quinolone, Cephalosporin, and Macrolide Use in Ambulatory Care
    • 99-02: Cost of Care for Individuals With Cystic Fibrosis in Alberta: A Regression Approach to Determining Important Cost Drivers
    • 99-01: The Roles of Health Economics in Canadian Drug Firms


  • 1998 working papers 
    • 98-12: The Classification and Measurement of Private Health-Related Costs: Application to HIV/AIDS
    • 98-11: Measuring and Predicting ICU Cost Per Patient Day: a Literature Review
    • 98-10: Cost Effectiveness of Streetworks Needle Exchange Program of Edmonton, Alberta
    • 98-09: Determinants and Consequences of Technological Change in Health Care: Acute Myocardial Infarction (AMI) in Alberta, Canada
    • 98-08: Burden of Illness of Employees on U.S. Employers
    • 98-07: Wages, Alcohol Use, and Smoking: Simultaneous Estimates
    • 98-06: Comparison of the EQ-5D and SF-12 in a General Population Survey in Alberta, Canada
    • 98-05: A Cost-Utility Analysis of Pacemakers for the Treatment of Neurally Mediated Syncope
    • 98-04: Nedocromil Sodium as Single Dose Prophylactic Treatment of Exercise-Induced Bronchoconstriction in Asthma: A Meta-Analysis
    • 98-03: National Pharmacare, Reference-Based Pricing, and Drug R & D:A Critique of The National Forum on Health's Recommendations For Pharmaceutical Policy
    • 98-02: Alberta-Based SF-12 Summary Scores
    • 98-01: Measuring Quality of Life in Pediatric Patients


Back to Previous Page

Back to Subject Index





Don't just start a business.
Start a successful one!

Know the Facts.  Get the Stats!